Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 17 August 2027
- Last conf. stmt
- 3 August 2026
Beacon Therapeutics Holdings Limited
- Incorporated
- 18 August 2022 (4 years)
- Previously known as
- SPL 123 Limited (until 1 June 2023)This list may be incomplete. See all names on Companies House
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Colin WalshWouter Sebastian James Joustra
- Owned by
- Syncona Limited
- Accounts type
- Group
- Region
- Greater London
- Address
- Rolling Stock Yard188 York WayLondonN7 9AS
Officers 9 active
Officer details are public data from the Companies House register.
Walsh, Colin, Dr.
Director · Appointed 23 December 2025
American
Born May 1985 (41)
American
Born October 1972 (54)
Joustra, Wouter Sebastian James
Director · Appointed 3 July 2024
Dutch
Born July 1988 (38)
Chester, Cariad Dixon
Director · Appointed 3 July 2024
American
Born July 1991 (35)
Hristodorov, Dimitrij, Dr
Director · Appointed 3 July 2024
German
Born May 1986 (40)
British
Born February 1967 (59)
Fellows, David Andrew
Director · Appointed 31 March 2023
American
Born August 1956 (70)
Director · Appointed 18 August 2022
British
Born December 1974 (51)
Director · Appointed 18 August 2022
Also at Quell Therapeutics Limited · more companies
Italian,Canadian
Born January 1979 (47)
Officer history (4 former)
23 December 2025
Appointed Walsh, Colin, Dr. as Director
21 December 2025
Resigned Kaplan, Lester, Dr as Director
3 October 2024
3 July 2024
Resigned John, Markus Robert, Dr as Director
3 July 2024
Appointed Joustra, Wouter Sebastian James as Director
3 July 2024
3 July 2024
3 July 2024
Appointed Hristodorov, Dimitrij, Dr as Director
3 July 2024
Appointed Chester, Cariad Dixon as Director
1 May 2023
1 May 2023
Appointed Kaplan, Lester, Dr as Director
31 March 2023
31 March 2023
Appointed John, Markus Robert, Dr as Director
31 March 2023
31 March 2023
Appointed Fellows, David Andrew as Director
18 August 2022
18 August 2022
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Syncona Limited
Corporate entity · Notified 18 August 2022
Owns 25–50% of shares
Holds 25–50% of voting rights
Company Limited By Shares
Reg. no. 55514
Holdings 1
Companies where Beacon Therapeutics Holdings Limited is registered as a person with significant control
Owns 75–100% of shares
Active
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 31 October 2026 | Statement of capital following an allotment of shares | |||
| 17 August 2026 | Confirmation statement with updates | 3 August 2026 |
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →